Literature DB >> 11825662

Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells.

Yasuyoshi Sasahara1, Michihiro Mutoh, Mami Takahashi, Kazunori Fukuda, Naomi Tanaka, Takashi Sugimura, Keiji Wakabayashi.   

Abstract

Butyrate suppresses the growth of colon cancer cells, inducing differentiation and apoptosis in vitro. Increased expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) has been suggested to be closely involved in colon carcinogenesis. In this study, effects of sodium butyrate on the promoter-dependent transcriptional activity of iNOS and COX-2 genes were investigated in a colon cancer cell line, DLD-1, using a reporter gene assay system. Sodium butyrate significantly reduced promoter-dependent iNOS transcriptional activity dose-dependently at concentrations higher than 0.1 mM. COX-2 transcriptional activity was not suppressed, but slightly increased. While hyperacetylated histones appeared at concentrations of sodium butyrate suppressing iNOS gene promoter activity, promoter-dependent transcriptional activities of iNOS and COX-2 genes were both increased by the histone deacetylase inhibitor trichostatin A. These results suggested that sodium butyrate exhibits differential effects on iNOS and COX-2 genes, acting to suppress iNOS expression via mechanisms independent of histone acetylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825662     DOI: 10.1016/s0304-3835(01)00778-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.

Authors:  Song-Lin Shi; Yong-Ye Wang; Ying Liang; Qi-Fu Li
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 2.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

Review 3.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

4.  Inducible nitric oxide synthase expression inhibition by adenovirus E1A.

Authors:  Wangsen Cao; Clare Bao; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

5.  Sesamol suppresses cyclooxygenase-2 transcriptional activity in colon cancer cells and modifies intestinal polyp development in Apc (Min/+) mice.

Authors:  Satomi Shimizu; Gen Fujii; Mami Takahashi; Ruri Nakanishi; Masami Komiya; Misato Shimura; Nobuharu Noma; Wakana Onuma; Masaru Terasaki; Tomohiro Yano; Michihiro Mutoh
Journal:  J Clin Biochem Nutr       Date:  2014-02-19       Impact factor: 3.114

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.